KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Assets Average (2016 - 2026)

NovoCure's Assets Average history spans 12 years, with the latest figure at $796.1 million for Q1 2026.

  • On a quarterly basis, Assets Average fell 36.04% to $796.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $796.1 million, a 36.04% decrease, with the full-year FY2025 number at $1.0 billion, down 14.32% from a year prior.
  • Assets Average hit $796.1 million in Q1 2026 for NovoCure, down from $1.1 billion in the prior quarter.
  • Over the last five years, Assets Average for NVCR hit a ceiling of $1.3 billion in Q3 2025 and a floor of $796.1 million in Q1 2026.
  • Historically, Assets Average has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
  • Biggest five-year swings in Assets Average: grew 9.79% in 2025 and later crashed 36.04% in 2026.
  • Tracing NVCR's Assets Average over 5 years: stood at $1.2 billion in 2022, then dropped by 3.1% to $1.1 billion in 2023, then increased by 7.43% to $1.2 billion in 2024, then dropped by 12.07% to $1.1 billion in 2025, then fell by 26.47% to $796.1 million in 2026.
  • Business Quant data shows Assets Average for NVCR at $796.1 million in Q1 2026, $1.1 billion in Q4 2025, and $1.3 billion in Q3 2025.